Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: Superiority of B7-1 over B7-2 for active tumor immunization

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2909-2917

  Gajewski, Thomas F ^a   Fallarino, Francesca ^b   Uyttenhove, Catherine ^b   Boon, Thierry ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL; ARTICLE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; DBA MOUSE; FEMALE; GRAFT REJECTION; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PHYSIOLOGY; SARCOMA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; FEMALE; GRAFT REJECTION; IMMUNITY, ACTIVE; IMMUNOCONJUGATES; LIGANDS; MAST-CELL SARCOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; MICE, NUDE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030584849     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991 The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp. Med. 173.1373.
2. Van der Bruggen, P., C. Traversari, P. Chomez, C Lurquin, E. De Plaen, B. Van den Eynde. A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643
3. Boon, T., J Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes Annu. Rev. Immunol 12. 337.
4. Colombo, M P., and G. Forni. 1994. Cytokine gene transfer in tumor inhibition and tumor therapy where are we now? Immunol Today 15:48.
5. Lauing, J , H. Kawasaki, E. Tanaka, Y. Luo, and M. E. Dorf. 1994. Inhibition of in vivo tumor growth by the β chemokine, TCA3. J. Immunol. 153:4625
6. + T cells by B7-transfected melanoma cells. Science 259.368.
7. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity J. Exp. Med. 179:523.
8. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181: 619.
9. Chen, L., P. S. Linsley, and K. E Hellstrom. 1993. Costimulation of T cells for tumor immunity. Immunol. Today 14:483.
10. Brichard, V. G., G. Warmer, A Van Pel, G Morlighem, S. Lucas, and T. Boon. 1995. Individual differences in the orientation of the cytolytic T cell responses against mouse tumor P815. Eur. J. Immunol. 25:664.
11. Van Pel, A., P. Van der Bruggen, P. G Coulie, V G. Brichard, B. Lethe, B. Van den Eynde, C. Uyttenhove, J.-C. Renauld, and T. Boon. 1995 Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev. In Press.
12. Uyttenhove, C , J. Van Snick, and T. Boon 1980. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J. Exp. Med. 152:1173.
13. Sibille, C., P. Chomez, C. Wildmann, A. Van Pel, E. De Plaen, J. L Maryanski, V. de Bergeyck, and T. Boon. 1990 Structure of the gene of turn transplantation antigen P198: a point mutation generates a new antigenic peptide J. Exp. Med. 172:35.
14. - antigen with a cytolytic T cell stimulation assay. Immunogenetics 26.178
15. - mutation. Proc. Natl. Acad Sci. USA 85.2274.
16. Coulie, P. G., F. Lehmann, B. Lethe, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl Acad. Sci. USA. 92.7976.
17. Van Pel, A , E De Plaen. and T. Boon. 1985. Selection of a highly transfectable variant from mouse mastocytoma P815. Somatic. Cell Mol. Genet 11:467.
18. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
19. Gajewski, T. F., J.-C. Renauld, A. Van Pel, and T. Boon. 1995 Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro J. Immunol. 154.5637.
20. Van Gool, S. W., M. de Boer, and J L. Ceuppens. 1993. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 150:3254.
21. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J A Ledbetter, C. Singh, and M. A. Tepper. 1992 Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257.792
22. Lenschow, D J , Y. Zeng, J R. Thistlethwaite, A. Montag, W. Brady, M G Gibson, P S, Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
23. Mizushima, S. and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322
24. de la Luna, S., I. Soria, D. Pulido, J. Ortin. and A. Jimenez 1988. Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker Gene 62 121
25. Linsley, P. S., W. Brady, M Umes, L. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174-561.
26. Brunet, J.-F., F Denizot, M -F. Luciani, M. Roux-Dosseto, M. Suzan, M -G. Mattel, and P. Golstein. 1987. A new member of the immunoglobuhn superfamily: CTLA-4. Nature 328:267.
27. Lancki, D W., A. Weiss, and F. W. Fitch. 1987 Requirements for triggering of lysis by cytolytic T lymphocyte clones: J. Immunol. 138:3646.
28. Alegre, M L., H. S. Sartar, J. Y. Tso, J. Smith, F Desalle, M Cole, and J. A. Bluestone. 1995. An anti-murine CD3 monoclonal antibody with a low affinity for Fey-receptors suppresses transplantation responses while minimizing toxicity and immunogenicity J. Immunol. 155:1544.
29. Yang, G., K E Hellstrom, I. Hellstrom, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules J. Immunol. 154:2794
30. Huang, A. Y. C., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.. Science 264:961.
31. Dranoff, G., E. Jaffee, A. Lazenby, P Golumbek, H. Levitsky, K. Brose, V Jackson, H. Hamada, D. Pardoll, and R. O Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc. Natl Acad Sci. USA 90:3539.
32. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differently the Thl/Th2 developmental pathways: application to autoimmune disease therapy Cell 80.707.
33. + T lymphocytes in the P815 tumor system in vitro. J Immunol. 156:465.
34. Linsley, P S., J L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793
35. Dohring, C., L. Angman, G. Spagnoli, and A. Lanzavecchia. 1994. T-helper- and accessory-cell-independent cytoloxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J Cancer 57:754.
36. De Plaen, E., K. Arden, C. Travcrsari, J. J. Gaforio, J. Szikora, C. De Smet, F Brasseur, P. Van der Bruggen, B Lethe, C Liuquin, R Brasseur, P. Chomez, O. De Backer, W. Cavenee, and T. Boon 1994 Structure, chromosomal location, and expression of 12 genes of the MAGE family. Immunogenetics 40:360.